AORT(Artivion, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $298.84M | $313.79M | $354.00M | $388.54M | $441.33M |
| 毛利润 | $197.51M | $202.52M | $229.18M | $248.78M | $284.23M |
| 营业利润 | $8.12M | $6.20M | $5.74M | $38.87M | $33.74M |
| 净利润 | −$14.83M | −$19.19M | −$30.69M | −$13.36M | $9.77M |
| 经营现金流 | −$2.58M | −$5.15M | $18.82M | $22.24M | $39.88M |
| 自由现金流 | −$15.68M | −$15.87M | $9.07M | $11.05M | $839.00K |
| 摊薄每股收益 | $-0.38 | $-0.48 | $-0.75 | $-0.32 | $0.21 |